Affirm (AFRM) Stock Is Up Big Two Days Running — Here’s Why Citi Is Watching Closely

15-Apr-2026 CoinCentral

TLDR

  • AFRM gapped up Wednesday, opening at $58.40 vs. a prior close of $55.82, last trading at $59.32 on volume of ~2.4 million.
  • Citi Research analyst Bryan Keane placed an “Upside 90-Day Catalyst Watch” on AFRM ahead of its May 12 investor day.
  • Keane expects management to set medium-term revenue growth targets above 20% and tighten profitability margins.
  • A LendingTree survey found 47% of BNPL users missed payments in the past year, up from 41% in 2025 — but it didn’t dent the stock.
  • AFRM is down 20% year-to-date but has climbed over 14% across two sessions this week; Wall Street consensus sits at “Moderate Buy” with an average price target of $85.

Affirm’s most recent earnings showed $0.37 EPS vs. the $0.28 consensus estimate — a beat of $0.09. Revenue came in at $1.12 billion, up 29.6% year-over-year, topping analyst expectations of $1.06 billion. Net margin was 7.6%, with a return on equity of 8.83%.


AFRM Stock Card
Affirm Holdings, Inc., AFRM

Despite that strong quarter, the stock has been under pressure. AFRM is down 20% in 2026 as rising consumer default rates and a rough environment for fintech have weighed on sentiment. So Wednesday’s move got attention.

The stock climbed 6.7% on the day, extending a 7.4% gain from the session before. The catalyst was a note from Citi Research analyst Bryan Keane, who placed an “Upside 90-Day Catalyst Watch” on AFRM ahead of the company’s May 12 investor day.

Keane believes management will use that event to refresh medium-term targets first set in 2023 — targets the company has, in his words, “since sustainably outperformed.”

What Citi Expects at the May 12 Investor Day

Keane is looking for a medium-term revenue growth outlook above 20%. He also expects Affirm to tighten its revenue less transaction costs (RLTC) margin guidance to a range of 3.5% to 4% of gross merchandise volume, up from a prior outlook of 3% to 4%.

The company’s CFO, Rob O’Hare, said on the last earnings call that RLTC take rates are expected to exceed 4% for both the third and fourth fiscal quarters of 2026.

Keane also pencils in GAAP operating margin guidance of 18% to 20%, alongside a GAAP tax rate assumption of around 20%. He holds a Buy rating and a $100 price target on the stock.

The broader analyst picture is constructive. Of 28 analysts tracked, one has a Strong Buy, 19 a Buy, and eight a Hold. The consensus is “Moderate Buy” with a $85 average price target. Cantor Fitzgerald has a $85 target; Oppenheimer sits at $83 with an “outperform” rating; Compass Point has a $68 Buy target.

Goldman Sachs cut AFRM from Buy to Hold in February.

BNPL Pain Points in Focus

The rally happened despite a fresh report from LendingTree that put a spotlight on BNPL credit stress. The survey of over 2,000 consumers found 47% were late on a BNPL payment in the past year, up from 41% in 2025 and 34% in 2024.

More than half of respondents said they relied on BNPL loans “to make ends meet.” Nearly a third reported using BNPL to pay for groceries.

Affirm’s COO Michael Linford pushed back on the BNPL label in February, telling Barron’s the company is “at its core, a software company” and that lumping Affirm with the broader BNPL category is “a bit of a shortcut.”

The stock trades at a P/E of 72.82, a PEG ratio of 3.60, and a beta of 3.63. Its 50-day moving average is $49.42; its 200-day moving average is $64.17. Institutional investors hold 69.29% of the stock.

The post Affirm (AFRM) Stock Is Up Big Two Days Running — Here’s Why Citi Is Watching Closely appeared first on CoinCentral.

Also read: Comment Lucid Motors a trouvé son PDG en cherchant dans l’industrie des ascenseurs
About Author Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nunc fermentum lectus eget interdum varius. Curabitur ut nibh vel velit cursus molestie. Cras sed sagittis erat. Nullam id ante hendrerit, lobortis justo ac, fermentum neque. Mauris egestas maximus tortor. Nunc non neque a quam sollicitudin facilisis. Maecenas posuere turpis arcu, vel tempor ipsum tincidunt ut.
WHAT'S YOUR OPINION?
Related News